Clinical Medicine Insights: Case Reports 2014:7 49-51
Case report
Published on 19 Jun 2014
DOI: 10.4137/CCRep.S15790
Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Case Reports
Patients with invasive giant prolactinoma suffer from a constellation of symptoms including headache, blurred vision, lethargy, and sexual dysfunction. Cabergoline, a potent dopamine agonist, is a known medication prescribed for the treatment of invasive giant prolactinoma. Here, we report a case of invasive giant prolactinoma in a 52-year-old Saudi male with dramatic response to cabergoline treatment clinically, biochemically, and radiologically.
PDF (840.70 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
PMC HTML
The experience with the journal was excellent. The submission process with simple, reviews were expedited quickly, and communication with the corresponding author was excellent.
Facebook Google+ Twitter
Pinterest Tumblr YouTube